Shamji; Alykhan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shamji; Alykhan.The latest application filed is for "uses of salt-inducible kinase (sik) inhibitors for treating osteoporosis".

Company Profile

10.7.15

Shamji; Alykhan - Somerville MA
Shamji; Alykhan - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis App 20220305016 - Wein; Marc ; et al.	2022-09-29
Compositions and methods for treating inflammatory bowel disease Grant 11,382,908 - Leshchiner , et al. July 12, 2	2022-07-12
Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity Grant 11,285,144 - Sundberg , et al. March 29, 2	2022-03-29
Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Grant 11,241,435 - Wein , et al. February 8, 2	2022-02-08
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20210147425 - Gray; Nathanael S. ; et al.	2021-05-20
Bicyclic urea kinase inhibitors and uses thereof Grant 10,954,242 - Gray , et al. March 23, 2	2021-03-23
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20200338087 - Shamji; Alykhan ; et al.	2020-10-29
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20200317675 - GRAY; Nathanael S. ; et al.	2020-10-08
Compositions And Methods For Treating Inflammatory Bowel Disease App 20200268736 - Leshchiner; Elizaveta ; et al.	2020-08-27
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis App 20200179387 - Wein; Marc ; et al.	2020-06-11
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20190343842 - Shamji; Alykhan ; et al.	2019-11-14
Bicyclic Urea Kinase Inhibitors And Uses Thereof App 20190315752 - GRAY; Nathanael S. ; et al.	2019-10-17
Use Of Cdk8 Inhibitors To Treat Diseases Of Inflammation And Autoimmunity App 20190183881 - Sundberg; Thomas ; et al.	2019-06-20
Uses of salt-inducible kinase (SIK) inhibitors Grant 10,265,321 - Shamji , et al.	2019-04-23
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20180221379 - Shamji; Alykhan ; et al.	2018-08-09
Compounds and methods for the treatment of isocitrate dehydrogenase related diseases Grant 9,944,633 - Hussain , et al. April 17, 2	2018-04-17
Uses Of Salt-inducible Kinase (sik) Inhibitors App 20170224700 - Shamji; Alykhan ; et al.	2017-08-10
Compounds And Methods For The Treatment Of Isocitrate Dehydrogenase Related Diseases App 20160102087 - Hussain; Mahmud ; et al.	2016-04-14
Compounds and methods for the treatment of isocitrate dehydrogenase related diseases Grant 9,120,810 - Hussain , et al. September 1, 2	2015-09-01
Compounds And Methods For The Treatment Of Isocitrate Dehydrogenase Related Diseases App 20140100223 - Hussain; Mahmud ; et al.	2014-04-10
Compounds And Methods For Targeting Leukemic Stem Cells App 20130338092 - Hartwell; Kimberly ; et al.	2013-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.